Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal dexmedetomidine during lumbar disc surgery
IRCT20200127046282N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of dexmedetomidine in Herniated Lumbar Disk (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Bax/Bcl-2 apoptotic factor levels in cerebrospinal fluid and Caspase-3 levels in cerebrospinal fluid. Started Dec 2019; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
Herniated Lumbar Disk
Beyond the preview
Go deeper on IRCT20200127046282N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200127046282N1.